Is a complete WST research report available?

No complete published report is available for West Pharmaceutical Services, Inc. (WST) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

WST Stock Analysis, Forecast & Valuation

Market cap	23.7B
Revenue (ttm)	3.3B
Net income (ttm)	564.9M
EPS (ttm)	$7.81
Shares out	70.4M
P/E (trailing)	43.2x
P/E (forward)	36.4x
Dividend	$0.88 (0.26%)
Volume	876,135

Beta	1.16

Price target	$404	+19.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All WST indicators

Market & fundamental data

Available fields

287

Groups with data

Currency

USD

Showing 287 of 287 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000105770
Company name	West Pharmaceutical Services, Inc.
Country	United States
Country code	US
Cusip	955306105
Employees	10,800
Employees Change	200%
Employees Change Percent	1.89
Enterprise value	$23.6B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Instruments & Supplies
Industry PE	68.6
Industry PE Fwd	21.77
Isin	US9553061055
Last refreshed	2026-07-29
Market cap	$23.7B
Market cap category	Large-Cap
Price	$337
Price currency	USD
Rev Per Employee	308,037.04x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	3841
Symbol	WST
Website	https://www.westpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.38%
EV Earnings	41.77x
EV Sales Forward	6.9x
EV/EBIT	34.68x
EV/EBITDA	27.38x
EV/FCF	54.01x
EV/Sales	7.09x
FCF yield	1.84%
Forward P/E	36.35x
P/B ratio	7.93x
P/E ratio	43.15x
P/S ratio	7.13x
PE Ratio10 Y	44.38x
PE Ratio3 Y	42.11x
PE Ratio5 Y	42.32x
PEG ratio	2.41x
PS Forward	6.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.45%
EBITDA Margin	25.9%
FCF margin	13.13%
Gross margin	36.79%
Gross Profit	$1.2B
Gross Profit Growth	17.21%
Gross Profit Growth Q	20.19%
Gross Profit Growth3 Y	3.82%
Gross Profit Growth5 Y	4.27%
Net Income	$564.9M
Net Income Growth	15.83%
Net Income Growth Q	16.84%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	2.88%
Net Income Growth5 Y	1.7%
Pretax Margin	21.31%
Profit Margin	16.98%
Profit Per Employee	$52,306
Profitable Quarters	$34
Profitable Years	24
ROA	11.38
Roa5y	12.28
ROCE	19.8
ROE	19.09
Roe5y	22.16
ROIC	20.57
Roic5y	27.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.12%
Cagr15y	20.63%
Cagr1y	28.42%
Cagr20y	16.55%
Cagr3y	-1.43%
Cagr5y	-2.03%
Div CAGR10	6.25%
Div CAGR3	5.01%
Div CAGR5	5.29%
EPS Growth	16.82
EPS Growth Q	18.13
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	4.38
EPS Growth5 Y	2.67
FCF Growth	27.01%
FCF Growth Q	-20.71%
FCF Growth3 Y	3.26%
FCF Growth5 Y	9.03%
OCF Growth	-2.14%
OCF Growth Q	-29.98%
OCF Growth10 Y	11.85%
OCF Growth3 Y	-2.16%
OCF Growth5 Y	5.76%
Revenue Growth	12.38x
Revenue Growth Q	13.8x
Revenue Growth Quarters	7x
Revenue Growth Years	1x
Revenue Growth3 Y	5.1x
Revenue Growth5 Y	5.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.83
Assets	$4.1B
Cash	$435.8M
Current Assets	$1.8B
Current Liabilities	$640.5M
Debt	$316.5M
Debt EBITDA	$0.37
Debt Equity	$0.11
Debt FCF	$0.72
Equity	$3B
Interest Coverage	151.2
Liabilities	$1.1B
Long Term Assets	$2.3B
Long Term Liabilities	$445.7M
Net Cash	$119.3M
Net Cash By Market Cap	$0.5
Net Cash Growth	-40.79%
Net Debt EBITDA	$-0.14
Net Debt Equity	$-0.04
Net Debt FCF	$-0.27
Tangible Book Value	$2.9B
Tangible Book Value Per Share	$40.84
WACC	10.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.82
Inventory Turnover	4.84
Net Working Capital	$753.5M
Quick ratio	1.82
Working Capital	$1.2B
Working Capital Turnover	$2.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.16%
Dividend Growth	4.76%
Dividend Growth Years	33%
Dividend per share	$0.88
Dividend Years	54
Dividend Yield	0.26%
Ex Div Date	2026-07-29
Last Dividend	$0.22
Payout Frequency	Quarterly
Payout Ratio	11.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	345.63%
1Y total return	28.39%
200-day SMA	283.7
3Y total return	-4.23%
50-day SMA	336
50-day SMA vs 200-day SMA	50over200
5Y total return	-9.76%
All Time High	475.4
All Time High Change	-29.1%
All Time High Date	2021-09-09
All Time Low	1.16
All Time Low Change	29,052.25%
All Time Low Date	1980-12-11
ATR	11.29
Beta	1.16
Beta1y	1.04
Beta2y	0.75
Ch YTD	22.48
High	339.6
High52	386
High52 Date	2026-07-23
High52ch	-12.69%
Low	330.4
Low52	223.8
Low52 Date	2026-01-30
Low52ch	50.56%
Ma50ch	0.28%
Price vs 200-day SMA	18.77%
RSI	43.72
RSI Monthly	57.95
RSI Weekly	60.8
Sharpe ratio	0.78x
Sortino ratio	1.43
Total Return	1.42%
Tr YTD	22.77
Tr15y	1,567.53%
Tr1m	-3.88%
Tr1w	-6.13%
Tr3m	11.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	4
Analyst Price Target Top	$348
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$2.08
Earnings EPS Estimate Growth	13.04
Earnings Revenue Estimate	837,996,112x
Earnings Revenue Estimate Growth	9.33x
Operating Income	$730.8M
Operating Income Growth	16.52
Operating Income Growth Q	22.5
Operating Income Growth3 Y	1.3
Operating Income Growth5 Y	3.01
Operating margin	21.97
Price target	$404
Price Target Change	$19.86
Price Target Change Top	$3.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,889,716%
Float Percent	99.31%
Net Borrowing	-1,300,000
Shares Insiders	0.61%
Shares Institutions	103.48%
Shares Out	70,375,762
Shares Qo Q	-1.52%
Shares Yo Y	-1.16%
Short Float	3.38%
Short Ratio	2.9
Short Shares	3.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$404.3M
Adjusted OCF	629,600,000
Average Volume	842,277.45x
Bv Per Share	42.47
CAPEX	$-225.3M
Ch10y	329.7
Ch15y	1,422.1
Ch1m	-3.95
Ch1w	-6.19
Ch1y	27.89
Ch20y	1,712.8
Ch3m	11.52
Ch3y	-5.04
Ch5y	-10.94
Ch6m	40.11
Change	1.74%
Change From Open	0.73
Close	331.3
Days Gap	1
Depreciation Amortization	181,400,000
Dollar Volume	295,257,495
Earnings Date	2026-07-23
Earnings Time	bmo
EBIT	$680.4M
EBITDA	$861.8M
EPS	$7.81
F Score	7
FCF	$436.9M
FCF EV Yield	1.85x
FCF Per Share	$6.21
Financing CF	-496,700,000
Fiscal Year End	December
Founded	1,923
Goodwill	108,700,000
Graham Number	86.38984
Graham Upside	-74.37
Income Tax	$144.2M
Investing CF	-225,300,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-23
Last Report Date	2026-06-30
Last Split Date	2013-09-27
Last Split Type	Forward
Last10k Filing Date	2026-02-17
Lynch Fair Value	$39.05
Lynch Upside	-88.41
Ma150	287.1
Ma150ch	17.38%
Ma20	354.4
Ma20ch	-4.9%
Net CF	-73,900,000
Next Earnings Date	2026-10-22
Open	334.6
Optionable	Yes
P FCF Ratio	54.28
P FCF Ratio SBC	58.66
P OCF Ratio	35.81
P OCF Ratio SBC	37.67
Payment Date	2026-08-05
Position In Range	71.63
Ppne	1,824,200,000
Price Date	2026-07-28
Price EBITDA	$27.52
Ptbv Ratio	8.25
Relative Volume	1.04x
Revenue	3,326,800,000x
SBC By Revenue	0.98x
Share Based Comp	32,600,000
Tax By Revenue	4.33x
Tax Rate	20.34%
Tr20y	2,038.39%
Tr6m	40.43%
Us State	Pennsylvania
Volume	876,135
Z Score	13.94

West Pharmaceutical Services, Inc. (WST)

Coverage state: Market snapshot only — no published research

Generate the first WST analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · WST

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All WST indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on WST

Frequently asked questions